SparkRx is intended for patients 13 to 22 years of age with symptoms of depression, whose primary language is English with a reading level of 5th grade or above, and who have access to an Android/iOS smartphone or tablet.
SparkRx is intended only for patients who own a smartphone and are familiar with use of smartphone applications. Patients with posttraumatic stress disorder (PTSD) who are currently experiencing marked alterations in arousal or reactivity associated with traumatic events may find that the level of exposure related to guided behavioral activation exacerbates symptoms.
Patients with active suicidal ideation with intent or those who have had a past suicide attempt may still be given SparkRx to help treat depression but should not be given SparkRx to prevent, treat or mitigate active suicidal ideation with intent.
For full safety information, read the SparkRx Indications for Use
and Clinician Instructions for Use.